NCT06608251

Association of Plasma Metabolomic Biomarkers with Chronic Ischemic White Matter Injury

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Nanjing First Hospital, Nanjing Medical University · Academic / Other
• Sex: All
• Age: 45 Years
• Healthy volunteers: Accepted

Summary

The cases were screened according to the inclusion criteria, and after the patients signed the informed consent, the clinical data were collected, the imaging data were evaluated, and blood samples were taken for follow-up measurements. In the early morning of the second day after the patient was enrolled, 5mL of peripheral venous blood was drawn and sent to the neurology laboratory of our hospital for separation, and the detection of plasma metabolomics markers was performed.

Detailed description

In the early morning of the second day after the patient was enrolled, 5mL of peripheral venous blood was drawn and sent to the neurology laboratory of our hospital for separation, and the detection of plasma metabolomics markers was performed.Inluding CRP，Complete blood count，Liver and kidney function indicators，et.

Conditions

• Myelinopathy

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	white matter lesion	According to the results of magnetic resonance, they were divided into white matter degeneration group and non-white matter degeneration group

Timeline

• Start date: 2024-06-01
• Primary completion: 2025-05-31
• Completion: 2025-05-31
• First posted: 2024-09-23
• Last updated: 2024-09-23

Locations

1 site across 1 country: China